Home » History

Our History

 Track and record of
 success in oncology

2009   

Accelera was born

2010   

AAALAC Accreditation

2011   

Accelera is selected for inclusion within the European Union Network of Laboratories for the Validation of Alternative Methods (EU-NETVAL), established by the EU Commission

2012   

Collaboration with Medicine for Malaria Venture, for antimalarial drugs in order to select those with the least toxic effect possible

2013   

Collaboration with Karolinska development

2014   

Collaboration with Cellectis to complete preclinical studies of Cellectis’ lead product cadidate UCART19

2015   

Starting activity with CAR-T cells

– Efficacy models
– Pilot studies for cell engrafment, tolerability, surgical implantation
– GLP cell fate/biodistribution by FACS analysis
– GLP safety (toxicology)
– GLP tumorigenicity
– Pathology and necropsy
– Immunohistochemistry, qPCR/ddPCR

2016

Headline news: Gene therapy saves a 1-year-old girl from leukemia

2017

Collaboration with the Politecnico of Milan for the development of organ-on-chip technology on cardiomyocytes

2018

Proud to be among DNI partners

DNDi and partners developed a breakthrough treatment for sleeping sickness

People/Team
Mission, vision and values
Governance and Ethics & compliance
Financials
People/Team
Mission, vision and values
Governance and Ethics & compliance
Financials